Economic Evaluation of New MDR TB Regimens

Conditions:   Multi-drug Resistant Tuberculosis;   Extensively Drug-Resistant Tuberculosis;   Pulmonary Tuberculoses Interventions:   Drug: Bedaquiline;   Drug: Pretomanid;   Drug: Moxifloxacin;   Drug: Linezolid;   Drug: Clofazimine;   Drug: Standard Drugs Sponsors:   Medecins Sans Frontieres, Netherlands;   London School of Hygiene and Tropical Medicine;   Ministry of Health, Republic of Uzbekistan;   Ministry of Health, Belarus;   TB & HIV Investigative Network (THINK);   Liverpool School of Tropical Medicine;   Clinical HIV Reserach Unit, Wits Health Consortium;   LSHTM Clinical Research Department Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials